
News|Articles|January 5, 2024
Determining the best approach for your Container Closure Integrity Testing needs
Author(s)Eurofins
Container-Closure Integrity (CCI) is essential for ensuring the stability and safety of drug products over time. The USP recommends deterministic methods over older probabilistic ones like dye ingress, emphasizing the need to assess the significance of leakage in relation to product quality. Eurofins can assist in choosing and validating appropriate CCI testing methods tailored to specific product and closure system configurations, as there is no one-size-fits-all solution outlined in the USP.
Trending on Pharmaceutical Technology
1
GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing
2
How a 63-Patient Trial Delivered an FDA Approval
3
Ask the Expert: Complying with Standards
4
Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing
5